SPDR® S&P Biotech ETF (XBI)

Add to Watchlists
Create an Alert
70.52 -0.06  -0.09% NYSE Arca Apr 26, 13:32 Delayed 2m USD
View Full Chart
XBI Price Chart

XBI Key Stats

Expense Ratio 0.35%
Share Class Assets Under Management 3.225B
30-Day Average Daily Volume Upgrade
Net Asset Value 70.64
Discount or Premium to NAV -0.08%
Turnover Ratio 75.00

XBI Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 2.71% 0.62% 8
3M 12.46% 9.07% 5
6M 20.37% 9.45% 3
1Y 34.48% 6.37% 4
3Y 14.16% 9.57% 1
5Y 21.53% 16.63% 1
As of April 25, 2017
Returns for periods of 1 year and above are annualized.

XBI Asset Allocation

Type % Net % Long % Short
Cash 0.00 0.00 0.00
Stock 99.94% 99.94% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.06% 0.06% 0.00
As of April 24, 2017

XBI Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00
Greater Europe 0.00
United Kingdom 0.00
Europe Developed 0.00
Europe Emerging 0.00
Africa/Middle East 0.00
Greater Asia 0.00
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00
As of April 24, 2017
Region breakdown data is calculated by using the long position holdings of the portfolio.

XBI Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 100.0%
Industrials 0.00
Real Estate 0.00
Technology 0.00
Utilities 0.00
As of April 24, 2017

XBI Stock Market Capitalization

Giant 7.08%
Large 14.52%
Medium 26.60%
Small 33.63%
Micro 18.17%
As of April 24, 2017

XBI Stock Style Exposure

Large Cap Value 4.85%
Large Cap Blend 2.46%
Large Cap Growth 15.44%
Mid Cap Value 0.00
Mid Cap Blend 2.85%
Mid Cap Growth 25.18%
Small Cap Value 1.56%
Small Cap Blend 4.05%
Small Cap Growth 43.61%
As of April 24, 2017
View More Holdings

XBI Top 10 Holdings

Symbol Name % Weight Price % Chg
VRTX Vertex Pharmaceuticals Inc 3.08% 116.41 -0.73%
BIVV Bioverativ Inc 2.70% 57.98 +0.35%
IONS Ionis Pharmaceuticals Inc 2.69% 46.24 -3.43%
SRPT Sarepta Therapeutics Inc 2.56% 34.20 -4.50%
NBIX Neurocrine Biosciences Inc 2.51% 53.35 -0.50%
BMRN Biomarin Pharmaceutical Inc 2.49% 95.21 +1.08%
CELG Celgene Corp 2.44% 125.32 -0.16%
EXEL Exelixis Inc 2.42% 21.83 -1.13%
ABBV AbbVie Inc 2.41% 65.46 +0.55%
GILD Gilead Sciences Inc 2.39% 68.46 +2.00%
As of April 24, 2017
Advertisement

XBI One Page Reports

XBI Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Biotechnology Select Industry TR USD
100.0%

XBI Manager Info

Name Tenure
Karl Schneider 2.42 yrs
Michael Feehily 5.42 yrs
Raymond Donofrio 0.24 yrs

XBI Net Fund Flows

1M 31.43M
3M 134.76M
6M 217.07M
YTD 134.76M
1Y 494.97M
3Y 1.221B
5Y 1.552B
10Y 1.948B
As of March 31, 2017

XBI Risk Info

Beta (5Y) 1.447
Max Drawdown (All) 49.39%
Historical Sharpe (10Y) 0.733
Historical Sortino (All) 0.9451
30-Day Rolling Volatility 22.26%
Daily Value at Risk (VaR) 1% (All) 4.89%
Monthly Value at Risk (VaR) 1% (All) 21.40%

XBI Fundamentals

Dividend Yield TTM (4-26-17) 0.16%
SEC Yield (4-24-17) 0.02%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 8.796
Weighted Average Price to Book Ratio 5.383
Weighted Median ROE -10.44%
Weighted Median ROA -18.00%
Forecasted Dividend Yield 0.27%
Forecasted PE Ratio 23.64
Forecasted Price to Sales Ratio 4.273
Forecasted Price to Book Ratio 4.337
Number of Holdings 94
As of April 24, 2017

XBI Growth Estimates

Forecasted 5 Yr Earnings Growth 8.03%
Forecasted Book Value Growth 10.73%
Forecasted Cash Flow Growth 23.97%
Forecasted Earnings Growth 25.88%
Forecasted Revenue Growth 24.23%
As of April 24, 2017

XBI Comparables

Edit

XBI Attributes

Key Dates
Inception Date 1/31/2006
Last Annual Report Date 6/30/2016
Last Prospectus Date 10/31/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

XBI Excel Add-In Codes

  • Name: =YCI("XBI","name")
  • Broad Asset Class: =YCI("XBI", "broad_asset_class")
  • Broad Category: =YCI("XBI", "broad_category_group")
  • Prospectus Objective: =YCI("XBI", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.